Efficacy and Safety of Metformin for Melasma Treatment: A Systematic Review and Meta-Analysis

    December 2023 in “ Frontiers in Pharmacology
    Pajaree Mongkhon, Chidchanok Ruengorn, Ratanaporn Awiphan, Chabaphai Phosuya, Yongyuth Ruanta, Kednapa Thavorn, Sirinda Jamjanya, Mati Chuamanochan, Surapon Nochaiwong
    TLDR Topical metformin effectively treats melasma with minimal side effects.
    This systematic review and meta-analysis evaluated the efficacy and safety of metformin for treating melasma, including three randomized controlled trials with 140 patients. The study found that 15% topical metformin significantly reduced the Melasma Area Severity Index (MASI) score compared to placebo after 8 weeks. Additionally, 30% topical metformin showed similar efficacy to triple combination cream (TCC) in reducing the MASI score, with fewer adverse events, although the difference was not statistically significant. The conclusion suggests that topical metformin is as effective as TCC with minimal adverse effects, but further research with larger sample sizes and longer follow-up is needed.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 44 results

    Similar Research

    5 / 1000+ results